Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results - PubMed (original) (raw)
. 2003 Jun;88(6):2656-66.
doi: 10.1210/jc.2002-030005.
Affiliations
- PMID: 12788870
- DOI: 10.1210/jc.2002-030005
Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results
Graeme Eisenhofer et al. J Clin Endocrinol Metab. 2003 Jun.
Abstract
Measurements of plasma normetanephrine and metanephrine provide a highly sensitive test for diagnosis of pheochromocytoma, but false-positive results remain a problem. We therefore assessed medication-associated false-positive results and use of supplementary tests, including plasma normetanephrine responses to clonidine, to distinguish true- from false-positive results. The study included 208 patients with pheochromocytoma and 648 patients in whom pheochromocytoma was excluded. Clonidine-suppression tests were carried out in 48 patients with and 49 patients without the tumor. Tricyclic antidepressants and phenoxybenzamine accounted for 41% of false-positive elevations of plasma normetanephrine and 44-45% those of plasma and urinary norepinephrine. High plasma normetanephrine to norepinephrine or metanephrine to epinephrine ratios were strongly predictive of pheochromocytoma. Lack of decrease and elevated plasma levels of norepinephrine or normetanephrine after clonidine also confirmed pheochromocytoma with high specificity. However, 16 of 48 patients with pheochromocytoma had normal levels or decreases of norepinephrine after clonidine. In contrast, plasma normetanephrine remained elevated in all but 2 patients, indicating more reliable diagnosis using normetanephrine than norepinephrine responses to clonidine. Thus, in patients with suspected pheochromocytoma and positive biochemical results, false-positive elevations due to medications should first be eliminated. Patterns of biochemical test results and responses of plasma normetanephrine to clonidine can then help distinguish true- from false-positive results.
Similar articles
- Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT, Frystyk J, Poulsen PL. Christensen TT, et al. Scand J Clin Lab Invest. 2011 Dec;71(8):695-700. doi: 10.3109/00365513.2011.622410. Epub 2011 Oct 24. Scand J Clin Lab Invest. 2011. PMID: 22023043 - [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
Därr R, Lenders JW, Stange K, Kindel B, Hofbauer LC, Bornstein SR, Eisenhofer G. Därr R, et al. Dtsch Med Wochenschr. 2013 Jan;138(3):76-81. doi: 10.1055/s-0032-1327395. Epub 2013 Jan 8. Dtsch Med Wochenschr. 2013. PMID: 23299341 German. - False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
Schürfeld R, Pamporaki C, Peitzsch M, Rayes N, Sabri O, Rohm S, Biemann R, Sandner B, Tönjes A, Eisenhofer G. Schürfeld R, et al. Endocr Relat Cancer. 2023 Dec 1;31(1):e230063. doi: 10.1530/ERC-23-0063. Print 2024 Jan 1. Endocr Relat Cancer. 2023. PMID: 37955319 Free PMC article. - [Plasma metanephrine measurements make the diagnosis of pheochromocytoma easier].
Friberg P. Friberg P. Lakartidningen. 1998 May 20;95(21):2482-5. Lakartidningen. 1998. PMID: 9640923 Review. Swedish. - [Biological diagnosis of pheochromocytoma: impact of technological improvement].
Peyrin L, Mornex R. Peyrin L, et al. Ann Biol Clin (Paris). 1993;51(10-11):835-65. Ann Biol Clin (Paris). 1993. PMID: 8210060 Review. French.
Cited by
- Canadian Urological Association Best Practice Report: Long-term surveillance following resection of pheochromocytoma.
Kumar RM, Violette PD, Tran C, Tomiak E, Izard J, Bathini V, Rowe NE. Kumar RM, et al. Can Urol Assoc J. 2019 Dec;13(12):372-376. doi: 10.5489/cuaj.6254. Epub 2019 Sep 9. Can Urol Assoc J. 2019. PMID: 31799918 Free PMC article. No abstract available. - Malignant catatonia mimicking pheochromocytoma.
Wong S, Hughes B, Pudek M, Li D. Wong S, et al. Case Rep Endocrinol. 2013;2013:815821. doi: 10.1155/2013/815821. Epub 2013 Oct 22. Case Rep Endocrinol. 2013. PMID: 24251048 Free PMC article. - Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers HJLM, Castinetti F, Dralle H, Widimský J, Gimenez-Roqueplo AP, Eisenhofer G. Lenders JWM, et al. J Hypertens. 2020 Aug;38(8):1443-1456. doi: 10.1097/HJH.0000000000002438. J Hypertens. 2020. PMID: 32412940 Free PMC article. Review. - Extra-adrenal Pheochromocytoma in an Adolescent.
Abdullah I, Cossey K, Jeanmonod RK. Abdullah I, et al. West J Emerg Med. 2011 May;12(2):258-61. West J Emerg Med. 2011. PMID: 21691539 Free PMC article. - Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach.
Araujo-Castro M, Pascual-Corrales E, Nattero Chavez L, Martínez Lorca A, Alonso-Gordoa T, Molina-Cerrillo J, Lorca Álvaro J, Mínguez Ojeda C, Redondo López S, Barberá Durbán R, Polo López R, Moreno Mata N, Caballero Silva U, Pian H, Ruz-Caracuel I, Sanjuanbenito Dehesa A, Gómez Dos Santos V, Serrano Romero AB. Araujo-Castro M, et al. J Endocrinol Invest. 2021 Dec;44(12):2545-2555. doi: 10.1007/s40618-021-01649-7. Epub 2021 Jul 25. J Endocrinol Invest. 2021. PMID: 34304388 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical